Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-25-004733
Filing Date
2025-06-20
Accepted
2025-06-20 17:03:26
Documents
38
Period of Report
2025-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q qtzm_10q.htm   iXBRL 10-Q 515717
2 CERTIFICATION qtzm_ex311.htm EX-31.1 10183
3 CERTIFICATION qtzm_ex321.htm EX-32.1 5171
  Complete submission text file 0001477932-25-004733.txt   2285346

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA relia-20250430.xsd EX-101.SCH 26058
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE relia-20250430_lab.xml EX-101.LAB 138351
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE relia-20250430_cal.xml EX-101.CAL 23116
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE relia-20250430_pre.xml EX-101.PRE 109221
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE relia-20250430_def.xml EX-101.DEF 57845
41 EXTRACTED XBRL INSTANCE DOCUMENT qtzm_10q_htm.xml XML 301093
Mailing Address 15656 BERNARDO CENTER DRIVE, #801 SAN DIEGO CA 92127
Business Address 15656 BERNARDO CENTER DRIVE, #801 SAN DIEGO CA 92127 858-203-0312
Quantumzyme Corp. (Filer) CIK: 0001663038 (see all company filings)

EIN.: 364806481 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-56725 | Film No.: 251062204
SIC: 2860 Industrial Organic Chemicals
(CF Office: 08 Industrial Applications and Services)